Co-Founder and CEO, Wetpaint
Founder and CEO, Lighter Capital
Managing Director, D.E. Shaw and Co., L.P.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
ARCH Venture Partners managing director Steven Gillis is slated to give the keynote address to the Washington Biotechnology & Biomedical Association’s annual meeting. Gillis, the co-founder of Immunex in 1981, will reflect on the industry’s past and future as the state trade group marks 25 years. Gov. Jay Inslee is also slated to speak at the event, which costs $150 non-members. Members pay less. Prices increase Oct. 20. More information and registration is here.